A high-fidelity CRISPR-Cas13 system improves abnormalities associated with C9ORF72-linked ALS/FTD is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2023). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5R01GM141296-04
Development of Technologies for Efficient In Vivo Prime Editing
National Institutes of Health
Grant: 1R01NS123556-01A1
Development of a CRISPR-Cas13 Gene Therapy for SOD1-Linked ALS
National Institutes of Health
Grant: 1U01NS122102-01A1
Optimization of an in vivo base editing strategy to treat SOD1-linked ALS
National Institutes of Health
Grant: 3T32EB019944-03S1
Tissue microenvironment (TiMe) training program
Fields of Study
Keywords